Metabolic syndrome and cognitive decline among the oldest old in Okinawa: In search of a mechanism. The KOCOA project

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 67 A, Issue 2, 2012, Pages 126-134

  Katsumata, Yuriko ^a,b,c   Todoriki, Hidemi ^a   Higashiuesato, Yasushi ^b   Yasura, Shotoku ^d   Willcox, D Craig ^d,e   Ohya, Yusuke ^a   Willcox, Bradley J ^e,f   Dodge, Hiroko H ^c  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OKINAWA INTERNATIONAL UNIVERSITY   (Japan)

^e KUAKINI MEDICAL CENTER   (United States)

^f UNIVERSITY OF HAWAII   (United States)

Author keywords

Drosophila melanogaster; Fecundity; Heat shock; Life span; Protein to carbohydrate ratio

Indexed keywords

DROSOPHILA MELANOGASTER;

GLYCOSYLATED HEMOGLOBIN;

AGE; AGED; AGING; ARTICLE; BLOOD; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; JAPAN; MALE; METABOLIC SYNDROME X; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR;

AGE FACTORS; AGED, 80 AND OVER; AGING; COGNITION; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; JAPAN; MALE; METABOLIC SYNDROME X; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84856167075     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glr189     Document Type: Article

References (71)

1. Brookmeyer R, Gray S. Methods for projecting the incidence and prevalence of chronic diseases in aging populations: application to Alzheimer's disease. Stat Med. 2000;19:1481-1493. (Pubitemid 30346241)
2. Fujishima M, Kiyohara Y. Incidence and risk factors of dementia in a defined elderly Japanese population: the Hisayama study. Ann N Y Acad Sci. 2002;977:1-8. (Pubitemid 35418131)
3. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001;322:1447-1451. (Pubitemid 32575406)
4. Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001;56:42-48. (Pubitemid 32059650)
5. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA. 1995;274:1846-1851. (Pubitemid 26001260)
6. Vanhanen M, Koivisto K, Moilanen L, et al. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology. 2006;67:843-847. (Pubitemid 44394200)
7. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr, Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ. 2005;330:1360.
8. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64:277-281.
9. Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol. 2002;59:378-384. (Pubitemid 34208144)
10. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA. 2004;292:2237-2242. (Pubitemid 39473161)
11. Yaffe K, Weston AL, Blackwell T, Krueger KA. The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol. 2009;66:324-328.
12. Morley JE. The metabolic syndrome and aging. J Gerontol A Biol Sci Med Sci. 2004;59:139-142. (Pubitemid 38269144)
13. Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord. 2007;24:185-192. (Pubitemid 47312668)
14. van den Berg E, Biessels GJ, de Craen AJ, Gussekloo J, Westendorp RG. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology. 2007;69:979-985. (Pubitemid 47366051)
15. Forti P, Pisacane N, Rietti E, et al. Metabolic syndrome and risk of dementia in older adults. J Am Geriatr Soc. 2010;58:487-492.
16. Hughes TF, Borenstein AR, Schofield E, Wu Y, Larson EB. Association between late-life body mass index and dementia: the Kame Project. Neurology. 2009;72:1741-1746.
17. Piguet O, Grayson DA, Creasey H, et al. Vascular risk factors, cognition and dementia incidence over 6 years in the Sydney Older Persons Study. Neuroepidemiology. 2003;22:165-171. (Pubitemid 36469834)
18. Hestad K, Kveberg B, Engedal K. Low blood pressure is a better predictor of cognitive deficits than the apolipoprotein e4 allele in the oldest old. Acta Neurol Scand. 2005;111:323-328. (Pubitemid 40559408)
19. Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ. Low blood pressure and the risk of dementia in very old individuals. Neurology. 2003;61:1667-1672. (Pubitemid 38020809)
20. Le Couteur DG, Simpson SJ. Adaptive senectitude: the prolongevity effects of aging. J Gerontol A Biol Sci Med Sci. 2011;66:179-182.
21. Sekita A, Ninomiya T, Tanizaki Y, et al. Trends in prevalence of Alzheimer's disease and vascular dementia in a Japanese community: the Hisayama Study. Acta Psychiatr Scand. 2010;122:319-325.
22. Willcox DC, Willcox BJ, He Q, Wang NC, Suzuki M. They really are that old: a validation study of centenarian prevalence in Okinawa. J Gerontol A Biol Sci Med Sci. 2008;63:338-349. (Pubitemid 351738415)
23. Todoriki H, Willcox D, Willcox B. The effects of post-war dietary change on longevity and health in Okinawa. Okinawan J Am Studies. 2004;1:52-61.
24. Dodge HH, Katsumata Y, Todoriki H, et al. Comparisons of plasma/serum micronutrients between Okinawan and Oregonian elders: a pilot study. J Gerontol A Biol Sci Med Sci. 2010;65:1060-1067.
25. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-2414. (Pubitemid 23346995)
26. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
27. The Examination Committee of Criteria for ̀Obesity Disease' in Japan/Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J. 2002;66:987-992.
28. Sung KC, Rhee EJ. Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adults. Diabet Med. 2007;24:848-854. (Pubitemid 47093040)
29. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31:1473-1478.
30. Dodge HH, Meguro K, Ishii H, Yamaguchi S, Saxton JA, Ganguli M. Cross-cultural comparisons of the Mini-mental State Examination between Japanese and U.S. cohorts. Int Psychogeriatr. 2009;21:113-122.
31. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
32. Takechi H, Dodge HH. Scenery Picture Memory Test: a new type of quick and effective screening test to detect early stage Alzheimer's disease patients. Geriatr Gerontol Int. 2010;10:183-190.
33. Lezak MD. Neuropsychological Assessment. 3rd ed. New York: Oxford University Press; 1995.
34. Littell RC, Milliken GA, Stroup WW, et al. SAS for Mixed Models. 2nd ed. Cary, NC: SAS Institute; 2006.
35. Feart C, Samieri C, Rondeau V, et al. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA. 2009;302:638-648.
36. Jacqmin-Gadda H, Fabrigoule C, Commenges D, Dartigues JF. A 5-year longitudinal study of the Mini-Mental State Examination in normal aging. Am J Epidemiol. 1997;145:498-506. (Pubitemid 27111218)
37. Penninx BW, Nicklas BJ, Newman AB, et al. Metabolic syndrome and physical decline in older persons: results from the Health, Aging And Body Composition Study. J Gerontol A Biol Sci Med Sci. 2009;64:96-102.
38. Rasgon N, Jarvik L. Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis. J Gerontol A Biol Sci Med Sci. 2004;59:178-183; discussion 184-192. (Pubitemid 38269152)
39. Willcox BJ, Willcox DC, Ferrucci L. Secrets of healthy aging and longevity from exceptional survivors around the globe: lessons from octogenarians to supercentenarians. J Gerontol A Biol Sci Med Sci. 2008;63:1181-1185. (Pubitemid 352772038)
40. Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G. Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study. J Am Geriatr Soc. 2003;51:410-414. (Pubitemid 36348905)
41. Kivipelto M, Helkala EL, Hanninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology. 2001;56:1683-1689. (Pubitemid 32574567)
42. Schnaider Beeri M, Goldbourt U, Silverman JM, et al. Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology. 2004;63:1902-1907. (Pubitemid 39532388)
43. Hassing LB, Hofer SM, Nilsson SE, et al. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing. 2004;33:355-361. (Pubitemid 39077242)
44. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology. 2005;65:545-551. (Pubitemid 41170713)
45. Mielke MM, Zandi PP, Sjogren M, et al. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology. 2005;64:1689-1695. (Pubitemid 40695799)
46. Meyer JS, Rogers RL, Judd BW, Mortel KF, Sims P. Cognition and cerebral blood flow fluctuate together in multi-infarct dementia. Stroke. 1988;19:163-169. (Pubitemid 18084386)
47. Dandona P, James IM, Newbury PA, Woollard ML, Beckett AG. Cerebral blood flow in diabetes mellitus: evidence of abnormal cerebrovascular reactivity. Br Med J. 1978;2:325-326. (Pubitemid 8386447)
48. Melamed E, Lavy S, Bentin S, Cooper G, Rinot Y. Reduction in regional cerebral blood flow during normal aging in man. Stroke. 1980;11:31-35. (Pubitemid 10160373)
49. Spilt A, Weverling-Rijnsburger AW, Middelkoop HA, et al. Late-onset dementia: structural brain damage and total cerebral blood flow. Radiology. 2005;236:990-995. (Pubitemid 41170863)
50. Launer LJ. The epidemiologic study of dementia: a life-long quest? Neurobiol Aging. 2005;26:335-340. (Pubitemid 40082716)
51. Salthouse TA. When does age-related cognitive decline begin? Neurobiol Aging. 2009;30:507-514.
52. Beason-Held LL, Moghekar A, Zonderman AB, Kraut MA, Resnick SM. Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke. 2007;38:1766-1773. (Pubitemid 46850653)
53. Ruitenberg A, den Heijer T, Bakker SL, et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol. 2005;57:789-794. (Pubitemid 40798616)
54. Fassbender K, Simons M, Bergmann C, et al. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A. 2001;98:5856-5861. (Pubitemid 32435732)
55. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A. 1998;95:6460-6464. (Pubitemid 28249035)
56. Mauch DH, Nagler K, Schumacher S, et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 2001;294:1354-1357. (Pubitemid 33063104)
57. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science. 2002;298:789-791. (Pubitemid 35231524)
58. Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH, Mintz J. White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol. 2003;60:393-398. (Pubitemid 36314365)
59. Banks WA. The source of cerebral insulin. Eur J Pharmacol. 2004;490:5-12. (Pubitemid 38482157)
60. Park CR. Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev. 2001;25:311-323. (Pubitemid 32624374)
61. Farris W, Mansourian S, Chang Y, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A. 2003;100:4162-4167. (Pubitemid 36418174)
62. Dahle CL, Jacobs BS, Raz N. Aging, vascular risk, and cognition: blood glucose, pulse pressure, and cognitive performance in healthy adults. Psychol Aging. 2009;24:154-162.
63. Willcox BJ, Donlon TA, He Q, et al. FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci U S A. 2008;105:13987-13992.
64. Liao FF, Xu H. Insulin signaling in sporadic Alzheimer's disease. Sci Signal. 2009;2:pe36.
65. Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141-1145. (Pubitemid 126512042)
66. Stewart R, Masaki K, Xue QL, et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol. 2005;62:55-60. (Pubitemid 40105036)
67. Chang CC, Roberts BL. Feeding difficulty in older adults with dementia. J Clin Nurs. 2008;17:2266-2274.
68. Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H. Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 2008;29:693-706. (Pubitemid 351410525)
69. Ferreira I, Henry RM, Twisk JW, van Mechelen W, Kemper HC, Stehouwer CD. The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med. 2005;165:875-882. (Pubitemid 40575728)
70. Grant T, Soriano Y, Marantz PR, et al. Community-based screening for cardiovascular disease and diabetes using HbA1c. Am J Prev Med. 2004;26:271-275. (Pubitemid 38521067)
71. Yassine HN, Marchetti CM, Krishnan RK, Vrobel TR, Gonzalez F, Kirwan JP. Effects of exercise and caloric restriction on insulin resistance and cardiometabolic risk factors in older obese adults-a randomized clinical trial. J Gerontol A Biol Sci Med Sci. 2009;64:90-95.